Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction

Trial Profile

Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Mar 2018

At a glance

  • Drugs Varenicline (Primary) ; Naltrexone
  • Indications Alcoholism; Smoking withdrawal
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Mar 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
    • 07 Mar 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
    • 04 Oct 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top